Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
Leligdowicz A, Yindom LM, Onyango C, Sarge-Njie R, Alabi A, Cotten M, Vincent T, da Costa C, Aaby P, Jaye A, Dong T, McMichael A, Whittle H, Rowland-Jones S. Leligdowicz A, et al. Among authors: mcmichael a. J Clin Invest. 2007 Oct;117(10):3067-74. doi: 10.1172/JCI32380. J Clin Invest. 2007. PMID: 17823657 Free PMC article.
The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.
Jallow S, Leligdowicz A, Kramer HB, Onyango C, Cotten M, Wright C, Whittle HC, McMichael A, Dong T, Kessler BM, Rowland-Jones SL. Jallow S, et al. Among authors: mcmichael a. Eur J Immunol. 2015 Aug;45(8):2232-42. doi: 10.1002/eji.201545451. Epub 2015 Jun 24. Eur J Immunol. 2015. PMID: 26018465 Free PMC article.
Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.
Dorrell L, Yang H, Ondondo B, Dong T, di Gleria K, Suttill A, Conlon C, Brown D, Williams P, Bowness P, Goonetilleke N, Rostron T, Rowland-Jones S, Hanke T, McMichael A. Dorrell L, et al. Among authors: mcmichael a. J Virol. 2006 May;80(10):4705-16. doi: 10.1128/JVI.80.10.4705-4716.2006. J Virol. 2006. PMID: 16641264 Free PMC article.
Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China.
Dong T, Zhang Y, Xu KY, Yan H, James I, Peng Y, Blais ME, Gaudieri S, Chen X, Lun W, Wu H, Qu WY, Rostron T, Li N, Mao Y, Mallal S, Xu X, McMichael A, John M, Rowland-Jones SL. Dong T, et al. Among authors: mcmichael a. Blood. 2011 Jul 7;118(1):98-106. doi: 10.1182/blood-2010-06-291963. Epub 2011 May 11. Blood. 2011. PMID: 21562042 Free PMC article.
Multilayered defense in HLA-B51-associated HIV viral control.
Zhang Y, Peng Y, Yan H, Xu K, Saito M, Wu H, Chen X, Ranasinghe S, Kuse N, Powell T, Zhao Y, Li W, Zhang X, Feng X, Li N, Leligdowicz A, Xu X, John M, Takiguchi M, McMichael A, Rowland-Jones S, Dong T. Zhang Y, et al. Among authors: mcmichael a. J Immunol. 2011 Jul 15;187(2):684-91. doi: 10.4049/jimmunol.1100316. Epub 2011 Jun 13. J Immunol. 2011. PMID: 21670313 Free PMC article.
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses.
Abd Hamid M, Wang RZ, Yao X, Fan P, Li X, Chang XM, Feng Y, Jones S, Maldonado-Perez D, Waugh C, Verrill C, Simmons A, Cerundolo V, McMichael A, Conlon C, Wang X, Peng Y, Dong T. Abd Hamid M, et al. Among authors: mcmichael a. Cancer Immunol Res. 2019 Aug;7(8):1293-1306. doi: 10.1158/2326-6066.CIR-18-0885. Epub 2019 Jun 18. Cancer Immunol Res. 2019. PMID: 31213473
1,228 results